Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment-Reference-Cited by-同舟云学术

Target Expression, Generation, Preclinical Activity, and Pharmacokinetics of the BCMA-T Cell Bispecific Antibody EM801 for Multiple Myeloma Treatment

Published:2017-03 Issue:3 Volume:31 Page:396-410
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Seckinger Anja,Delgado Jose Antonio,Moser Samuel,Moreno Laura,Neuber Brigitte,Grab Anna,Lipp Susanne,Merino Juana,Prosper Felipe,Emde Martina,Delon Camille,Latzko Melanie,Gianotti Reto,Lüoend Remo,Murr Ramona,Hosse Ralf J.,Harnisch Lydia Jasmin,Bacac Marina,Fauti Tanja,Klein Christian,Zabaleta Aintzane,Hillengass Jens,Cavalcanti-Adam Elisabetta Ada,Ho Anthony D.,Hundemer Michael,San Miguel Jesus F.,Strein Klaus,Umaña Pablo,Hose Dirk,Paiva Bruno,Vu Minh Diem

Funder

EngMab AG

German Federal Ministry of Education

Deutsche Forschungsgemeinschaft

Cooperative Research Thematic Network

Instituto de Salud Carlos III

Asociación Española Contra el Cáncer

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference43 articles.